Sensitise public on alert against Coldrif cough syrup batch: Telangana govt directs health officials

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2025-10-06 07:45 GMT | Update On 2025-10-06 09:26 GMT

Hyderabad: The Director of Public Health, Telangana, has instructed all District Medical and Health Officers (DM&HOs) to actively sensitise the public about the alert, which was originally issued on September 4 by the Drugs Control Administration (DCA). The directive emphasizes the need to stop the use of Coldrif syrup of Batch No. SR-13, which has been allegedly found adulterated with Diethylene Glycol (DEG), a toxic substance.

If people are in possession of the syrup, they should immediately report to the local drug control authority on its toll free number, the communication (dated October 5), shared with the media on Monday, said.

The Director of Public Health also asked DM&HOs to strictly implement and disseminate the advisory issued by the Directorate General of Health Services (DGHS), Union Ministry of Health, regarding the judicious prescribing and dispensing of cough syrups for children.

The DGHS, in the advisory, stated that most acute cough illnesses in children are self-limiting and often resolve without pharmacological intervention.

Cough and cold medications should not be prescribed or dispensed to children under two years. They are generally not recommended for ages below five years, and above that, any use should follow careful clinical evaluation with close supervision and strict adherence to appropriate dosing and other relevant precautions.

As per PTI, the advisory also said all healthcare facilities and clinical establishments must ensure procurement and dispensing of products manufactured under Good Manufacturing Practices and formulated with pharmaceutical-grade excipients.

The Madhya Pradesh government on October 4 banned the sale of Coldrif syrup following the death of nine children due to suspected kidney infection in Chhindwara district since September 7.

Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Sensitise public on alert against Coldrif cough syrup batch: Telangana govt directs health officials

Similar News

FSSAI Bar on Dr Reddy's Nutraceutical Put on Hold: Delhi HC Awaits Regulatory Hearing Outcome

Doctors Slam FSSAI Inaction After Delhi HC Allows ORSL Sales, Warn of Child Health Risks

India deepens anti dumping probe into imports of anti TB drug ingredient from China, Thailand

Indian pharma, healthcare sector record 72 deals worth USD 3.5 billion in Q3 2025: Grant Thornton Bharat

Thermo Fisher Scientific inaugurates expanded RnD Centre of Excellence in Bengaluru

Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral Solution

Maha: Rs 14-Crore Mephedrone Unit Busted Near Police Station, Cop Suspended for Negligence

MP FDA Moves Rs 320-Crore Proposal to CDSCO, FSSAI to Upgrade Drug, Food Testing Labs